Anixa Biosciences to Present at Biotech Showcase 2024
SAN JOSE, Calif., Dec. 14, 2023 /PRNewswire/ — Anixa Biosciences, Inc. (“Anixa” or the “Company”) (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced that it will present an overview of its business and provide updates on its clinical programs at Biotech Showcase, taking place January 8-10, 2024 in San Francisco, California in parallel to the 42nd Annual J.P. Morgan Healthcare Conference (“JPM Week 2024”).
Related news for (ANIX)
- Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
- Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
- MoBot alert highlights: NASDAQ: XTLB, NASDAQ: QTTB, NASDAQ: BIAF, NASDAQ: ANIX, NASDAQ: NERV (10/07/25 07:00 PM)
- MoBot’s Stock Market Highlights – 10/07/25 03:00 PM
- 24/7 Market News Snapshot 07 October, 2025 – Anixa Biosciences, Inc. (NASDAQ:ANIX)
